| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
14,135 |
12,518 |
$1.24M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13,167 |
11,651 |
$764K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
7,887 |
7,415 |
$318K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,006 |
2,792 |
$227K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,633 |
2,543 |
$221K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,164 |
1,135 |
$96K |
| 87428 |
|
1,516 |
1,456 |
$70K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
551 |
539 |
$52K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,788 |
1,745 |
$42K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
764 |
602 |
$27K |
| 96127 |
|
3,890 |
3,711 |
$23K |
| 94760 |
|
8,171 |
7,396 |
$21K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,489 |
1,432 |
$20K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
946 |
919 |
$13K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
698 |
655 |
$12K |
| 99051 |
|
1,004 |
968 |
$12K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
272 |
198 |
$5K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
132 |
128 |
$5K |
| 87807 |
|
354 |
339 |
$5K |
| 99188 |
|
95 |
95 |
$3K |
| 99336 |
|
18 |
14 |
$2K |
| 90670 |
|
1,025 |
981 |
$2K |
| 90686 |
|
2,352 |
2,281 |
$2K |
| 0071A |
|
39 |
34 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
72 |
71 |
$966.17 |
| 0072A |
|
23 |
23 |
$920.00 |
| 86328 |
|
16 |
15 |
$720.89 |
| 90723 |
|
506 |
486 |
$573.28 |
| 90680 |
|
549 |
522 |
$399.76 |
| 90461 |
|
2,597 |
2,475 |
$197.05 |
| 99173 |
|
587 |
571 |
$156.93 |
| 90697 |
|
55 |
53 |
$139.82 |
| 90734 |
|
81 |
81 |
$113.32 |
| 90656 |
|
150 |
149 |
$103.68 |
| 81000 |
|
32 |
30 |
$96.30 |
| 81002 |
|
41 |
40 |
$91.45 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
72 |
41 |
$88.75 |
| 90685 |
|
146 |
141 |
$64.33 |
| 99072 |
|
63 |
63 |
$6.32 |
| 90633 |
|
106 |
106 |
$0.67 |
| 90649 |
|
61 |
61 |
$0.35 |
| 90648 |
|
107 |
104 |
$0.17 |
| 90715 |
|
13 |
13 |
$0.11 |
| 90677 |
|
269 |
257 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
55 |
52 |
$0.00 |
| 91307 |
|
91 |
83 |
$0.00 |
| 90647 |
|
12 |
12 |
$0.00 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
528 |
485 |
$0.00 |